Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K

Arthritis and Rheumatism

Volumn 52, Issue 12, 2005, Pages 3713-3717

  Morko, Jukka ^a   Kiviranta, Riku ^a   Joronen, Kirsi ^a   Säämänen, Anna Marja ^a   Vuorio, Eero ^a   Salminen Mankonen, Heli ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; FIBRILLAR COLLAGEN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FIBROSIS; GENE OVEREXPRESSION; HISTOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; SYNOVITIS; SYNOVIUM; TRANSGENIC MOUSE;

AGING; ANIMALS; CARTILAGE, ARTICULAR; CATHEPSINS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KNEE JOINT; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; PROMOTER REGIONS (GENETICS); SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 29144526738     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21423     Document Type: Article

References (15)

1. Kirschke H, Barret AJ, Rawlings ND. Lysosomal cysteine proteinases. New York: Oxford University Press; 1998. p. 2-27.
2. Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J. Liljestrom M, et al. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 2002;46:953-60.
3. Morko JP, Soderstrom M, Saamanen AM, Salminen HJ, Vuorio EI. Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis 2004;63:649-55.
4. Dodds RA, Connor JR, Drake FH, Gowen M. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum 1999;42:1588-93.
5. Hummel KM, Petrow PK, Franz JK, Muller-Ladner U, Aicher WK, Gay RE, et al. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 1998;25:1887-94.
6. Saamanen AK, Salminen HJ, Dean PB. De Crombrugghe B, Vuorio EI, Metsaranta MP. Osteoarthritis-like lesions in transgenic mice harboring a small deletion mutation in type II collagen gene. Osteoarthritis Cartilage 2000;8:248-57.
7. Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998;331:727-32.
8. Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, et al. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 2002;46:663-74.
9. Kiviranta R, Morko J, Uusitalo H, Aro HT, Vuorio E, Rantakokko J. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res 2001;16:1444-52.
10. Morko J, Kiviranta R, Hurme S, Rantakokko J, Vuorio E. Differential turnover of cortical and trabecular bone in transgenic mice overexpressing cathepsin K. Bone 2005;36:854-65.
11. Joronen K, Ala-aho R, Majuri ML, Alenius H, Kahari VM, Vuorio E. Adenovirus mediated intra-articular expression of collagenase-3 (MMP-13) induces inflammatory arthritis in the mouse. Ann Rheum Dis 2004;63:656-64.
12. Xia L, Kilb J, Wex H, Li Z, Lipyansky A, Breuil V, et al. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem 1999;380:679-87.
13. Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, et al. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 2005;36:159-72.
14. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000;43:250-8.
15. Pelletier JP, Boileau C, Brunei J, Boily M, Lajeunesse D, Reboul P, et al. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone 2004;34:527-38.